Three-Statement Breakdown
REVENUE UP
Revenue rose 8.5% year over year to $88.3B, and carried a 12.4% net margin.
REVENUE
+8.5%
88,309
GROSS PROFIT
—
—
NET INCOME
-3.1%
10,992
EPS (DILUTED)
+0.6%
$9.72
| Income statement | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
|
43,310 | 44,998 | 68,397 | 80,118 | 79,571 | 78,558 | 81,400 | 88,309 | +8.5% |
| SG&A |
|
(13,161) | (14,139) | (18,926) | (20,238) | (21,607) | (21,311) | (20,818) | (23,470) | +12.7% |
| Operating income |
|
5,309 | 5,722 | 6,636 | 6,892 | 6,543 | 14,266 | 18,010 | 18,279 | +1.5% |
| Interest expense |
|
(835) | (727) | (2,483) | (3,189) | -3,364 | -3,335 | -3,411 | -3,774 | — |
| Income tax |
|
(1,029) | (1,135) | (786) | (327) | (556) | (2,682) | (3,373) | (3,289) | -2.5% |
| Net income |
|
2,888 | 3,468 | 3,064 | 3,024 | 2,590 | 8,317 | 11,339 | 10,992 | -3.1% |
| EPS (diluted) |
|
$3.36 | $4.02 | $2.65 | $2.41 | $2.06 | $6.93 | $9.66 | $9.72 | +0.6% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-23 ↗